

House
Study
Bill
214
-
Introduced


SENATE/HOUSE
FILE
_____


BY
(PROPOSED
GOVERNOR
BILL)


A
BILL
FOR


An
Act
relating
to
the
prescribing
and
dispensing
of
1


self-administered
hormonal
contraceptives.
2


BE
IT
ENACTED
BY
THE
GENERAL
ASSEMBLY
OF
THE
STATE
OF
IOWA:
3


TLSB
1826XL
(18)
88


pf/rh



S.F.
_____
H.F.
_____


Section
1.
Section
155A.3,
Code
2019,
is
amended
by
adding
1


the
following
new
subsections:
2


NEW
SUBSECTION


.
10A.
“Department”
means
the
department
of
3


public
health.
4


NEW
SUBSECTION


.
44A.
“Self-administered
hormonal
5


contraceptive”
means
a
self-administered
hormonal
contraceptive
6


that
is
approved
by
the
United
States
food
and
drug
7


administration
to
prevent
pregnancy.
“Self-administered
8


hormonal
contraceptive”
includes
an
oral
hormonal
contraceptive,
9


a
hormonal
vaginal
ring,
and
a
hormonal
contraceptive
patch,
10


but
does
not
include
any
drug
intended
to
induce
an
abortion
as
11


defined
in
section
146.1.
12


NEW
SUBSECTION


.
44B.
“Standing
order”
means
a
preauthorized
13


medication
order
with
specific
instructions
from
the
medical
14


director
of
the
department
to
dispense
a
medication
under
15


clearly
defined
circumstances.
16


Sec.
2.
NEW
SECTION


.
155A.47
Pharmacist
dispensing
of
17


self-administered
hormonal
contraceptives
——
standing
order
——
18


requirements
——
limitations
of
liability.
19


1.
Notwithstanding
any
provision
of
law
to
the
contrary,
a
20


pharmacist
may
dispense,
at
one
time,
up
to
a
one-year
supply
21


of
a
self-administered
hormonal
contraceptive
to
a
patient
22


who
is
at
least
eighteen
years
of
age,
pursuant
to
a
standing
23


order
established
by
the
medical
director
of
the
department
in
24


accordance
with
this
section.
25


2.
A
pharmacist
who
dispenses
a
self-administered
hormonal
26


contraceptive
in
accordance
with
this
section
shall
not
27


require
any
other
prescription
drug
order
authorized
by
a
28


practitioner
prior
to
dispensing
the
self-administered
hormonal
29


contraceptive
to
a
patient.
30


3.
The
medical
director
of
the
department
may
establish
a
31


standing
order
authorizing
the
dispensing
of
self-administered
32


hormonal
contraceptives
by
a
pharmacist
who
does
all
of
the
33


following:
34


a.
Complies
with
the
standing
order
established
pursuant
to
35


-1-


LSB
1826XL
(18)
88


pf/rh


1/
10







S.F.
_____
H.F.
_____


this
section.
1


b.
Retains
a
record
of
each
patient
to
whom
a
2


self-administered
hormonal
contraceptive
is
dispensed
under
3


this
section
and
submits
the
record
to
the
department.
4


4.
The
standing
order
shall
require
a
pharmacist
who
5


dispenses
self-administered
hormonal
contraceptives
under
this
6


section
to
do
all
of
the
following:
7


a.
Complete
a
standardized
training
program
and
continuing
8


education
requirements
approved
by
the
board
in
consultation
9


with
the
department
that
are
related
to
prescribing
10


self-administered
hormonal
contraceptives
and
include
education
11


regarding
all
contraceptive
methods
approved
by
the
United
12


States
food
and
drug
administration.
13


b.
Obtain
a
completed
self-screening
risk
assessment,
14


approved
by
the
department
in
collaboration
with
the
board
and
15


the
board
of
medicine,
from
each
patient
prior
to
dispensing
16


the
self-administered
hormonal
contraceptive
to
the
patient.
17


c.
Provide
the
patient
with
all
of
the
following:
18


(1)
Written
information
regarding
all
of
the
following:
19


(a)
The
importance
of
completing
an
appointment
with
the
20


patient’s
primary
care
or
women’s
health
care
practitioner
21


to
obtain
preventative
care,
including
but
not
limited
to
22


recommended
tests
and
screenings.
23


(b)
The
effectiveness
and
availability
of
long-acting
24


reversible
contraceptives
as
an
alternative
to
25


self-administered
hormonal
contraceptives.
26


(2)
A
copy
of
the
record
of
the
pharmacist’s
encounter
with
27


the
patient
that
includes
all
of
the
following:
28


(a)
The
patient’s
completed
self-screening
risk
assessment.
29


(b)
A
description
of
the
contraceptive
dispensed,
or
the
30


basis
for
not
dispensing
a
contraceptive.
31


(3)
Patient
counseling
regarding
all
of
the
following:
32


(a)
The
appropriate
administration
and
storage
of
the
33


self-administered
hormonal
contraceptive.
34


(b)
Potential
side
effects
and
risks
of
the
35


-2-


LSB
1826XL
(18)
88


pf/rh


2/
10



S.F.
_____
H.F.
_____


self-administered
hormonal
contraceptive.
1


(c)
The
need
for
backup
contraception.
2


(d)
When
to
seek
emergency
medical
attention.
3


(e)
The
risk
of
contracting
a
sexually
transmitted
4


infection
or
disease,
and
ways
to
reduce
such
a
risk.
5


5.
The
standing
order
established
pursuant
to
this
section
6


shall
prohibit
a
pharmacist
who
dispenses
a
self-administered
7


hormonal
contraceptive
under
this
section
from
doing
any
of
the
8


following:
9


a.
Requiring
a
patient
to
schedule
an
appointment
with
10


the
pharmacist
for
the
prescribing
or
dispensing
of
a
11


self-administered
hormonal
contraceptive.
12


b.
Dispensing
self-administered
hormonal
contraceptives
to
13


a
patient
for
more
than
twenty-four
months
after
the
date
a
14


self-administered
hormonal
contraceptive
is
initially
dispensed
15


to
the
patient
without
the
patient’s
attestation
that
the
16


patient
has
consulted
with
a
primary
care
or
women’s
health
17


care
practitioner
during
the
preceding
twenty-four
months.
18


c.
Dispensing
a
self-administered
hormonal
contraceptive
to
19


a
patient
if
the
results
of
the
self-screening
risk
assessment
20


completed
by
a
patient
pursuant
to
subsection
4,
paragraph
21


“b”
,
indicate
it
is
unsafe
for
the
pharmacist
to
dispense
the
22


self-administered
hormonal
contraceptive
to
the
patient,
in
23


which
case
the
pharmacist
shall
refer
the
patient
to
a
primary
24


care
or
women’s
health
care
practitioner.
25


6.
A
pharmacist
who
dispenses
a
self-administered
hormonal
26


contraceptive
and
the
medical
director
of
the
department
who
27


establishes
a
standing
order
in
compliance
with
this
section
28


shall
be
immune
from
criminal
and
civil
liability
arising
29


from
any
damages
caused
by
the
dispensing,
administering,
30


or
use
of
a
self-administered
hormonal
contraceptive
or
the
31


establishment
of
the
standing
order.
The
medical
director
of
32


the
department
shall
be
considered
to
be
acting
within
the
33


scope
of
the
medical
director’s
office
and
employment
for
34


purposes
of
chapter
669
in
the
establishment
of
a
standing
35


-3-


LSB
1826XL
(18)
88


pf/rh


3/
10



S.F.
_____
H.F.
_____


order
in
compliance
with
this
section.
1


7.
The
department,
in
collaboration
with
the
board
and
2


the
board
of
medicine,
and
in
consideration
of
the
guidelines
3


established
by
the
American
congress
of
obstetricians
and
4


gynecologists,
shall
adopt
rules
pursuant
to
chapter
17A
to
5


administer
this
chapter.
6


Sec.
3.
Section
514C.19,
Code
2019,
is
amended
to
read
as
7


follows:
8


514C.19
Prescription
contraceptive
coverage.
9


1.
Notwithstanding
the
uniformity
of
treatment
requirements
10


of
section
514C.6
,
a
group
policy
,


or
contract
,
or
plan
11


providing
for
third-party
payment
or
prepayment
of
health
or
12


medical
expenses
shall
not
do
either
of
the
following
comply
13


as
follows


:
14


a.
Exclude
Such
policy,
contract,
or
plan
shall
not
15


exclude
or
restrict
benefits
for
prescription
contraceptive
16


drugs
or
prescription
contraceptive
devices
which
prevent
17


conception
and
which
are
approved
by
the
United
States
18


food
and
drug
administration,
or
generic
equivalents
19


approved
as
substitutable
by
the
United
States
food
and
drug
20


administration,
if
such
policy
,


or
contract
,
or
plan
provides
21


benefits
for
other
outpatient
prescription
drugs
or
devices.
22


However,
such
policy,
contract,
or
plan
shall
specifically


23


provide
for
payment
of
a
one-year
supply
of
self-administered
24


hormonal
contraceptives,
as
prescribed
by
a
practitioner
as
25


defined
in
section
155A.3,
or
as
prescribed
by
standing
order
26


and
dispensed
by
a
pharmacist
pursuant
to
section
155A.47,
27


including
self-administered
hormonal
contraceptives
dispensed
28


at
one
time.
29


b.
Exclude


Such
policy,
contract,
or
plan
shall
not
exclude
30


or
restrict
benefits
for
outpatient
contraceptive
services
31


which
are
provided
for
the
purpose
of
preventing
conception
if
32


such
policy
,


or
contract
,
or
plan
provides
benefits
for
other
33


outpatient
services
provided
by
a
health
care
professional.
34


2.
A
person
who
provides
a
group
policy
,


or
contract
,
or
35


-4-


LSB
1826XL
(18)
88


pf/rh


4/
10






























S.F.
_____
H.F.
_____


plan
providing
for
third-party
payment
or
prepayment
of
health
1


or
medical
expenses
which
is
subject
to
subsection
1
shall
not
2


do
any
of
the
following:
3


a.
Deny
to
an
individual
eligibility,
or
continued
4


eligibility,
to
enroll
in
or
to
renew
coverage
under
the
terms
5


of
the
policy
,


or
contract
,
or
plan
because
of
the
individual’s
6


use
or
potential
use
of
such
prescription
contraceptive
drugs
7


or
devices,
or
use
or
potential
use
of
outpatient
contraceptive
8


services.
9


b.
Provide
a
monetary
payment
or
rebate
to
a
covered
10


individual
to
encourage
such
individual
to
accept
less
than
the
11


minimum
benefits
provided
for
under
subsection
1
.
12


c.
Penalize
or
otherwise
reduce
or
limit
the
reimbursement
13


of
a
health
care
professional
because
such
professional
14


prescribes
contraceptive
drugs
or
devices,
or
provides
15


contraceptive
services.
16


d.
Provide
incentives,
monetary
or
otherwise,
to
a
health
17


care
professional
to
induce
such
professional
to
withhold
18


from
a
covered
individual
contraceptive
drugs
or
devices,
or
19


contraceptive
services.
20


3.
This
section
shall
not
be
construed
to
prevent
a
21


third-party
payor
from
including
deductibles,
coinsurance,
or
22


copayments
under
the
policy
,


or
contract,
or
plan
as
follows:
23


a.
A
deductible,
coinsurance,
or
copayment
for
benefits
24


for
prescription
contraceptive
drugs
shall
not
be
greater
than
25


such
deductible,
coinsurance,
or
copayment
for
any
outpatient
26


prescription
drug
for
which
coverage
under
the
policy
,
or
27


contract
,
or
plan
is
provided.
28


b.
A
deductible,
coinsurance,
or
copayment
for
benefits
for
29


prescription
contraceptive
devices
shall
not
be
greater
than
30


such
deductible,
coinsurance,
or
copayment
for
any
outpatient
31


prescription
device
for
which
coverage
under
the
policy
,


or
32


contract
,
or
plan
is
provided.
33


c.
A
deductible,
coinsurance,
or
copayment
for
benefits
for
34


outpatient
contraceptive
services
shall
not
be
greater
than
35


-5-


LSB
1826XL
(18)
88


pf/rh


5/
10
















S.F.
_____
H.F.
_____


such
deductible,
coinsurance,
or
copayment
for
any
outpatient
1


health
care
services
for
which
coverage
under
the
policy
,


or
2


contract
,
or
plan
is
provided.
3


4.
This
section
shall
not
be
construed
to
require
a
4


third-party
payor
under
a
policy
,


or
contract
,
or
plan
5


to
provide
benefits
for
experimental
or
investigational
6


contraceptive
drugs
or
devices,
or
experimental
or
7


investigational
contraceptive
services,
except
to
the
extent
8


that
such
policy
,


or
contract
,
or
plan
provides
coverage
for
9


other
experimental
or
investigational
outpatient
prescription
10


drugs
or
devices,
or
experimental
or
investigational
outpatient
11


health
care
services.
12


5.
This
section
shall
not
be
construed
to
limit
or
otherwise
13


discourage
the
use
of
generic
equivalent
drugs
approved
by
the
14


United
States
food
and
drug
administration,
whenever
available
15


and
appropriate.
This
section
,
when
a
brand
name
drug
is
16


requested
by
a
covered
individual
and
a
suitable
generic
17


equivalent
is
available
and
appropriate,
shall
not
be
construed
18


to
prohibit
a
third-party
payor
from
requiring
the
covered
19


individual
to
pay
a
deductible,
coinsurance,
or
copayment
20


consistent
with
subsection
3
,
in
addition
to
the
difference
of
21


the
cost
of
the
brand
name
drug
less
the
maximum
covered
amount
22


for
a
generic
equivalent.
23


6.
A
person
who
provides
an
individual
policy
,


or
contract
,
24


or
plan
providing
for
third-party
payment
or
prepayment
of
25


health
or
medical
expenses
shall
make
available
a
coverage
26


provision
that
satisfies
the
requirements
in
subsections
27


1
through
5
in
the
same
manner
as
such
requirements
are
28


applicable
to
a
group
policy
,
or
contract
,
or
plan
under
those
29


subsections.
The
policy
,


or
contract
,
or
plan
shall
provide
30


that
the
individual
policyholder
may
reject
the
coverage
31


provision
at
the
option
of
the
policyholder.
32


7.
a.
This
section
applies
to
the
following
classes
of
33


third-party
payment
provider
contracts
,


or
policies
,
or
plan
34


delivered,
issued
for
delivery,
continued,
or
renewed
in
this
35


-6-


LSB
1826XL
(18)
88


pf/rh


6/
10

























S.F.
_____
H.F.
_____


state
on
or
after
July
1,
2000
January
1,
2020
:
1


(1)
Individual
or
group
accident
and
sickness
insurance
2


providing
coverage
on
an
expense-incurred
basis.
3


(2)
An
individual
or
group
hospital
or
medical
service
4


contract
issued
pursuant
to
chapter
509
,
514
,
or
514A
.
5


(3)
An
individual
or
group
health
maintenance
organization
6


contract
regulated
under
chapter
514B
.
7


(4)
Any
other
entity
engaged
in
the
business
of
insurance,
8


risk
transfer,
or
risk
retention,
which
is
subject
to
the
9


jurisdiction
of
the
commissioner.
10


(5)
A
plan
established
pursuant
to
chapter
509A
for
public
11


employees.
12


b.
This
section
shall
not
apply
to
accident-only,
13


specified
disease,
short-term
hospital
or
medical,
hospital
14


confinement
indemnity,
credit,
dental,
vision,
Medicare
15


supplement,
long-term
care,
basic
hospital
and
medical-surgical
16


expense
coverage
as
defined
by
the
commissioner,
disability
17


income
insurance
coverage,
coverage
issued
as
a
supplement
18


to
liability
insurance,
workers’
compensation
or
similar
19


insurance,
or
automobile
medical
payment
insurance.
20


8.


This
section
shall
not
be
construed
to
require
a
21


third-party
payor
to
provide
payment
to
a
practitioner
for
the
22


dispensing
of
a
self-administered
hormonal
contraceptive
to


23


replace
a
self-administered
hormonal
contraceptive
that
has
24


been
dispensed
to
a
covered
person
and
that
has
been
misplaced,
25


stolen,
or
destroyed.
This
section
shall
not
be
construed
to
26


require
a
third-party
payor
to
replace
covered
prescriptions
27


that
are
misplaced,
stolen,
or
destroyed.
28


9.
For
the
purposes
of
this
section:
29


a.


“Self-administered
hormonal
contraceptive”
means
a
30


self-administered
hormonal
contraceptive
that
is
approved
31


by
the
United
Sates
food
and
drug
administration
to
prevent


32


pregnancy.


“Self-administered
hormonal
contraceptive”
includes
33


an
oral
hormonal
contraceptive,
a
hormonal
vaginal
ring,
and


34


a
hormonal
contraceptive
patch,
but
does
not
include
any
drug
35


-7-


LSB
1826XL
(18)
88


pf/rh


7/
10





























S.F.
_____
H.F.
_____


intended
to
induce
an
abortion
as
defined
in
section
146.1.
1


b.


“Standing
order”
means
a
preauthorized
medication
order
2


with
specific
instructions
from
the
medical
director
of
the
3


department
of
public
health
to
dispense
a
medication
under
4


clearly
defined
circumstances.


5


EXPLANATION
6


The
inclusion
of
this
explanation
does
not
constitute
agreement
with
7


the
explanation’s
substance
by
the
members
of
the
general
assembly.
8


This
bill
relates
to
the
dispensing
of
self-administered
9


hormonal
contraceptives
by
a
pharmacist.
The
bill
10


defines
“self-administered
hormonal
contraceptive”
as
a
11


self-administered
hormonal
contraceptive
that
is
approved
by
12


the
United
States
food
and
drug
administration
to
prevent
13


pregnancy,
including
an
oral
hormonal
contraceptive,
a
hormonal
14


vaginal
ring,
and
a
hormonal
contraceptive
patch,
but
not
15


including
any
drug
intended
to
induce
an
abortion.
16


The
bill
provides
that
notwithstanding
any
provision
of
17


law
to
the
contrary,
a
pharmacist
may
dispense
at
one
time,
18


up
to
a
one-year
supply
of
a
self-administered
hormonal
19


contraceptive
to
a
patient
who
is
at
least
18
years
of
age
20


pursuant
to
a
standing
order
established
by
the
medical
21


director
of
the
department
of
public
health
(medical
director).
22


Additionally,
the
bill
prohibits
a
pharmacist
who
dispenses
23


a
self-administered
hormonal
contraceptive
in
accordance
24


with
the
bill
from
requiring
any
other
prescription
drug
25


order
authorized
by
a
practitioner
prior
to
dispensing
the
26


self-administered
hormonal
contraceptive.
27


The
bill
authorizes
the
medical
director
to
establish
a


28


standing
order
authorizing
the
dispensing
of
self-administered
29


hormonal
contraceptives
by
any
pharmacist
who
complies
with
the
30


standing
order
and
retains
and
submits
the
patient’s
record
to
31


the
department
of
public
health
(DPH).
32


The
standing
order
includes
requiring
a
pharmacist
who
33


dispenses
a
self-administered
hormonal
contraceptive
under
34


the
bill
to:
complete
a
standardized
training
program
and
35


-8-


LSB
1826XL
(18)
88


pf/rh


8/
10











S.F.
_____
H.F.
_____


continuing
education
requirements
related
to
prescribing
the
1


hormonal
contraceptives;
obtain
a
completed
self-screening
risk
2


assessment
from
each
patient
before
dispensing
the
hormonal
3


contraceptives;
provide
the
patient
with
certain
written
4


information;
provide
the
patient
with
a
copy
of
the
record
5


of
the
pharmacist’s
encounter
with
the
patient;
and
provide
6


patient
counseling.
7


The
standing
order
is
to
prohibit
a
pharmacist
who
dispenses
8


hormonal
contraceptives
under
the
bill
from
requiring
a
9


patient
to
schedule
an
appointment
with
the
pharmacist
for
10


the
prescribing
or
dispensing
of
the
hormonal
contraceptives;
11


dispensing
the
hormonal
contraceptives
to
a
patient
for
more
12


than
24
months
after
the
date
initially
dispensed
without
the
13


patient’s
attestation
that
the
patient
has
consulted
with
a
14


practitioner
during
the
preceding
24
months;
or
dispensing
the
15


hormonal
contraceptives
to
a
patient
if
the
results
of
the
16


patient’s
self-screening
risk
assessment
indicate
it
is
unsafe
17


for
the
pharmacist
to
dispense
the
hormonal
contraceptives
18


to
the
patient,
in
which
case
the
pharmacist
shall
refer
the
19


patient
to
a
practitioner.
20


The
bill
provides
immunity,
for
a
pharmacist
who
dispenses
a
21


self-administered
hormonal
contraceptive
and
for
the
medical
22


director
who
establishes
a
standing
order
in
compliance
with
23


the
bill,
from
criminal
and
civil
liability
arising
from
any
24


damages
caused
by
the
dispensing,
administering,
or
use
of
a
25


self-administered
hormonal
contraceptive
or
the
establishment
26


of
the
standing
order.
Additionally,
the
medical
director
27


shall
be
considered
to
be
acting
within
the
scope
of
the
28


medical
director’s
office
and
employment
for
purposes
of
Code
29


chapter
669
(Iowa
tort
claims
Act)
in
the
establishment
of
a
30


standing
order
in
compliance
with
the
bill.
31


The
bill
requires
DPH,
in
collaboration
with
the
boards
of
32


pharmacy
and
medicine,
and
in
consideration
of
the
guidelines
33


established
by
the
American
congress
of
obstetricians
and
34


gynecologists,
to
adopt
administrative
rules
to
administer
the
35


-9-


LSB
1826XL
(18)
88


pf/rh


9/
10



S.F.
_____
H.F.
_____


bill.
1


The
bill
amends
prescription
contraceptive
coverage
2


provisions
to
require
that
a
group
policy,
contract,
or
plan
3


delivered,
issued
for
delivery,
continued,
or
renewed
in
the
4


state
on
or
after
January
1,
2020,
providing
for
third-party
5


payment
or
prepayment
of
health
or
medical
expenses,
shall
6


specifically
provide
for
payment
of
a
one-year
supply
of
7


self-administered
hormonal
contraceptives,
as
prescribed
8


and
dispensed
as
specified
in
the
bill,
including
those
9


dispensed
at
one
time.
The
bill
provides,
however,
that
10


the
provisions
of
the
bill
relating
to
coverage
are
not
11


to
be
construed
to
require
a
third-party
payor
to
provide
12


payment
to
a
practitioner
for
dispensing
a
self-administered
13


hormonal
contraceptive
to
replace
a
self-administered
14


hormonal
contraceptive
that
has
been
dispensed
to
a
covered
15


person
and
that
has
been
misplaced,
stolen,
or
destroyed.
16


These
provisions
are
also
not
to
be
construed
to
require
a
17


third-party
payor
to
replace
covered
prescriptions
that
are
18


misplaced,
stolen,
or
destroyed.
19


-10-


LSB
1826XL
(18)
88


pf/rh


10/
10

